MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Surgical

Diabetes: Chinese kids nearly 4 times more at-risk than U.S. peers | MassDevice.com On Call

By Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Chinese teenagers exhibit rates of diabetes nearly 4 times higher than U.S. teenagers, according to a new report from University of North Carolina at Chapel Hill researchers.

The study is the longest of its kind of China, following more than 29,000 patients in 300 communities from 1989 to 2011, using data from the China Health & Nutrition Surveys.

The results, published in Obesity Reviews, suggest that 15% of Chinese children aged 7-17 have symptoms of pre-diabetes, and 2% are diabetic.

MassDevice.com +3 | The top 3 med-tech stories for June 13, 2012.

By Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Sanofi snags hydrogel maker Pluromed for an undisclosed amount

By Leave a Comment

Sanofi logo
Pluromed logo

French health care giant Sanofi (NYSE:SNY) signed a definitive agreement to acquire hydrogel maker Pluromed for an undisclosed amount.

Sanofi plans to commercialize Woburn, Mass.-based Pluromed’s LeGoo polymer plug, an injectable gel used during surgical procedures in place of a clamp or snare.

Zimmer to snatch up Synvasive Technology

By Leave a Comment

Zimmer

Zimmer Holdings (NYSE:ZMH) agreed to acquire Synvasive Technology, a Reno, Nev.-based maker of surgical saws and cutting tools, for an undisclosed sum.

Warsaw, Ind.-based Zimmer will roll Synvasive’s StableCut surgical saw blades and eLibra knee balancing systems into its reconstructive division, which includes ZMH’s knees, hips and extremities business. That division brought in $417 million during the company’s most recent fiscal quarter.

Cardica plunges after halting trial

By Leave a Comment

Cardica

Cardica (NSDQ:CRDC) shares fell more than 20% today after the company said it halted enrollment in a European clinical trial of its MicroCutter XPress 30 because the device "did not perform satisfactorily in thicker tissue" in a small number of cases.

There were no adverse events associated with the problem, but Cardica will have to modify the device, according to a press release.

Intuitive adds to the da Vinci surgical system arsenal | Regulatory Roundup

By Leave a Comment

Mela

Intuitive Surgical (NSDQ:ISRG) won FDA clearance for its EndoWrist vessel sealer designed for use with the company’s da Vinci surgical robot.

The Sunnyvale, Calif.-based med-tech maker’s device is wristed to give clinicians full control over vessel sealing in vessels up to 7mm.

GPOs: Premier rolls out 6 new supply contracts

By Leave a Comment

Group purchasing organization goliath Premier health care alliance inked 6 new supply deals for surgical endoscopy, video and MRI compatible equipment.

Premier signed 3 new agreements for surgical endoscopy and video equipment with Olympus America (TYO:7733), Gyrus ACMI and Kalamazoo, Mich.-based med-tech titan Stryker Corp. (NYSE:SYK) .